These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8505866)

  • 1. Measurement of left ventricular mass in hypertrophic cardiomyopathy using MRI: comparison with echocardiography.
    Allison JD; Flickinger FW; Wright JC; Falls DG; Prisant LM; VonDohlen TW; Frank MJ
    Magn Reson Imaging; 1993; 11(3):329-34. PubMed ID: 8505866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of Real Time 3D Echocardiography for the Assessment of Left Ventricular Mass in Patients with Hypertrophic Cardiomyopathy: Comparison with Cardiac Magnetic Resonance.
    Avegliano GP; Costabel JP; Asch FM; Sciancalepore A; Kuschnir P; Huguet M; Tobon-Gomez C; Frangi AF; Ronderos R
    Echocardiography; 2016 Mar; 33(3):431-6. PubMed ID: 26525462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the left ventricular anatomy in hypertrophic cardiomyopathy: comparison between echocardiography and cardiac magnetic resonance imaging.
    Romano R; Losi MA; Migliore T; Contaldi C; Parrella LS; Caputi A; Betocchi S
    Minerva Cardioangiol; 2008 Apr; 56(2):181-7. PubMed ID: 18319696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationships between left ventricular mass and QRS duration in diverse types of left ventricular hypertrophy.
    Domain G; Chouquet C; Réant P; Bongard V; Vedis T; Rollin A; Mandel F; Delasnerie H; Voglimacci-Stephanopoli Q; Mondoly P; Beneyto M; Cariou E; Fournier P; Delmas C; Galinier M; Carrié D; Lafitte S; Lairez O; Ferrières J; Cochet H; Maury P
    Eur Heart J Cardiovasc Imaging; 2022 Mar; 23(4):560-568. PubMed ID: 33842939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison between maximal left ventricular wall thickness and left ventricular mass in patients with hypertrophic cardiomyopathy.
    Spiewak M; Chojnowska L; Małek LA; Miłosz B; Petryka J; Zabicka M; Kłopotowski M; Dabrowski M; Miśko J; Ruzyłło W
    Kardiol Pol; 2010 Jul; 68(7):763-8. PubMed ID: 20648432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance imaging compared to echocardiography to assess left ventricular mass in the hypertensive patient.
    Bottini PB; Carr AA; Prisant LM; Flickinger FW; Allison JD; Gottdiener JS
    Am J Hypertens; 1995 Mar; 8(3):221-8. PubMed ID: 7794570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of MRI and echocardiography in hypertrophic cardiomyopathy.
    Devlin AM; Moore NR; Ostman-Smith I
    Br J Radiol; 1999 Mar; 72(855):258-64. PubMed ID: 10396215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Determination of left ventricular mass by transthoracic three-dimensional echocardiography in patients with dilated cardiomyopathy].
    Geil S; Rao L; Menzel T; Genth-Zotz S; Wittlinger T; Voigtländer T; Mohr-Kahaly S
    Z Kardiol; 1999 Nov; 88(11):922-31. PubMed ID: 10643060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left ventricular wall thickness in patients with hypertrophic cardiomyopathy: a comparison between cardiac magnetic resonance imaging and echocardiography.
    Corona-Villalobos CP; Sorensen LL; Pozios I; Chu L; Eng J; Abraham MR; Abraham TP; Kamel IR; Zimmerman SL
    Int J Cardiovasc Imaging; 2016 Jun; 32(6):945-54. PubMed ID: 26896038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of left ventricular mass between two-dimensional echocardiography, using fundamental and tissue harmonic imaging, and cardiac MRI in patients with hypertension.
    Alfakih K; Bloomer T; Bainbridge S; Bainbridge G; Ridgway J; Williams G; Sivananthan M
    Eur J Radiol; 2004 Nov; 52(2):103-9. PubMed ID: 15489067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Three-dimensional analysis of left ventricular geometry using magnetic resonance imaging: feasibility and comparison with echocardiographic analysis].
    Moriuchi M; Saito S; Kasamaki Y; Komaki K; Kanmatsuse K; Hayasaka K
    J Cardiol; 2003 Dec; 42(6):249-60. PubMed ID: 14723017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of cardiac magnetic resonance on the diagnosis of hypertrophic cardiomyopathy - a 10-year experience with over 1000 patients.
    Śpiewak M; Kłopotowski M; Ojrzyńska N; Petryka-Mazurkiewicz J; Miłosz-Wieczorek B; Mazurkiewicz Ł; Grzybowski J; Bilińska Z; Witkowski A; Marczak M
    Eur Radiol; 2021 Mar; 31(3):1194-1205. PubMed ID: 32876838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T1 Mapping in Discrimination of Hypertrophic Phenotypes: Hypertensive Heart Disease and Hypertrophic Cardiomyopathy: Findings From the International T1 Multicenter Cardiovascular Magnetic Resonance Study.
    Hinojar R; Varma N; Child N; Goodman B; Jabbour A; Yu CY; Gebker R; Doltra A; Kelle S; Khan S; Rogers T; Arroyo Ucar E; Cummins C; Carr-White G; Nagel E; Puntmann VO
    Circ Cardiovasc Imaging; 2015 Dec; 8(12):. PubMed ID: 26659373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of left ventricular mass measured by 3D echocardiography using magnetic resonance imaging as gold standard.
    Lenstrup M; Kjaergaard J; Petersen CL; Kjaer A; Hassager C
    Scand J Clin Lab Invest; 2006; 66(8):647-57. PubMed ID: 17101557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left ventricular mass in hypertrophic cardiomyopathy: assessment by three-dimensional and geometric MR methods.
    Soler R; Rodríguez E; Marini M
    J Comput Assist Tomogr; 1999; 23(4):577-82. PubMed ID: 10433290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of imaging in the diagnosis and management of hypertrophic cardiomyopathy.
    Weissler-Snir A; Crean A; Rakowski H
    Expert Rev Cardiovasc Ther; 2016; 14(1):51-74. PubMed ID: 26567960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hypertrophic cardiomyopathy with dilatation of the left ventricle and congestive heart failure: comparison with postmyocarditis cardiomegaly and hypertensive heart failure].
    Kawanishi H; Yokota Y; Hayakawa M; Kaku K; Kumaki T; Matsumoto K; Fujitani K; Ito Y; Inoh T; Fukuzaki H
    J Cardiogr; 1983 Sep; 13(3):537-50. PubMed ID: 6235295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasonic Assessment of Myocardial Microstructure in Hypertrophic Cardiomyopathy Sarcomere Mutation Carriers With and Without Left Ventricular Hypertrophy.
    Hiremath P; Lawler PR; Ho JE; Correia AW; Abbasi SA; Kwong RY; Jerosch-Herold M; Ho CY; Cheng S
    Circ Heart Fail; 2016 Sep; 9(9):. PubMed ID: 27623770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2D speckle-tracking TTE-based quantitative classification of left ventricular myocardium in patients with hypertrophic cardiomyopathy by the presence or the absence of fibrosis and/or hypertrophy.
    Funabashi N; Takaoka H; Ozawa K; Uehara M; Komuro I; Kobayashi Y
    Heart Vessels; 2018 Sep; 33(9):1046-1051. PubMed ID: 29569032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinguishing focal fibrotic lesions and non-fibrotic lesions in hypertrophic cardiomyopathy by assessment of regional myocardial strain using two-dimensional speckle tracking echocardiography: comparison with multislice CT.
    Yajima R; Kataoka A; Takahashi A; Uehara M; Saito M; Yamaguchi C; Lee K; Komuro I; Funabashi N
    Int J Cardiol; 2012 Jul; 158(3):423-32. PubMed ID: 21354635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.